{
  "authors": [
    {
      "author": "Inga-Marie Schaefer"
    },
    {
      "author": "Carsten-Oliver Sahlmann"
    },
    {
      "author": "Tobias Overbeck"
    },
    {
      "author": "Stefan Schweyer"
    },
    {
      "author": "Jan Menke"
    }
  ],
  "doi": "10.1186/1471-2407-12-424",
  "publication_date": "2012-09-26",
  "id": "EN116830",
  "url": "https://pubmed.ncbi.nlm.nih.gov/23006472",
  "source": "BMC cancer",
  "source_url": "",
  "licence": "CC BY",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "We here describe a case of blastomatoid pulmonary carcinosarcoma in a 58-year-old patient, who underwent surgical resection. Histopathological examination revealed immature glandular epithelium resembling high-grade fetal adenocarcinoma expressing epithelial markers and membranous beta-catenin, and blastomatoid spindle cells with partial rhabdomyosarcoma-like differentiation. Both elements expressed p53, MDM2, and cyclin-dependent kinase 4 (CDK4), but not thyroid-transcription factor 1 (TTF-1). Mutation analysis of KRAS, EGFR, and beta-catenin revealed no mutations. Comparative genomic hybridization detected +1q, +6p, +6q24qter, +8q, +11q12q14, +11q23qter, +12q12q21, +12q24qter, +17q, +20q, -5q14q23, -9p13pter, -13q21q21, and amplifications at 12q14q21, 15q24qter, 20q11q12."
}